Table 3 Direct medical costs and proportion of patient’s co-payment for prostate cancer in Korea from 2005 to 2014
Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
1 yr. before | 2956 (27.8) | 3307 (23.0) | 3532 (22.0) | 3793 (22.2) | 3854 (22.3) | 4020 (21.0) | 4206 (20.4) | 4183 (20.2) | 4058 (20.1) | 4141 (19.7) |
1st yr | 9077 (16.1) | 9890 (13.7) | 10,088 (16.7) | 10,448 (24.0) | 10,752 (24.6) | 11,025 (23.6) | 11,568 (22.9) | 11,305 (22.0) | 11,299 (22.0) | 11,741 (22.1) |
2nd yr | 6220 (13.9) | 6086 (14.6) | 5897 (15.1) | 5802 (13.7) | 5831 (12.7) | 5944 (12.1) | 5563 (12.8) | 5544 (12.9) | 5793 (12.4) | |
3rd yr | 5711 (14.9) | 5862 (15.2) | 5534 (14.3) | 5650 (13.0) | 5521 (12.9) | 5178 (13.4) | 5191 (13.4) | 5393 (13.3) | ||
4th yr | 5473 (15.7) | 5534 (14.3) | 5261 (13.5) | 5273 (13.4) | 4985 (13.7) | 5023 (13.9) | 5152 (13.8) | |||
5th yr | 5491 (14.5) | 5529 (13.8) | 5098 (13.7) | 5034 (14.2) | 4970 (14.1) | 5140 (14.3) | ||||
6th yr | 5437 (14.8) | 5211 (15.2) | 4767 (15.6) | 4603 (16.5) | 4900 (15.7) | |||||
7th yr | 5324 (14.8) | 5070 (15.2) | 4800 (16.0) | 4816 (16.2) | ||||||
8th yr | 4952 (16.1) | 4847 (15.8) | 4912 (15.9) | |||||||
9th yr | 4959 (16.4) | 5057 (15.9) | ||||||||
10th yr | 5079 (16.4) |